Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19 Elizabeth LeungRyan L. CrassNathaniel J. Rhodes Review Article 11 December 2021 Pages: 155 - 165
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions Robert HermannPeter KrajcsiAlain Munafo Review Article Open access 11 December 2021 Pages: 167 - 187
Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature Samuel DubinskyKevin WattAndrea Edginton Systematic Review 30 November 2021 Pages: 189 - 229
Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study Dirk Jan A. R. MoesDavid J. van WesterlooJudith van Paassen Original Research Article Open access 11 October 2021 Pages: 231 - 247
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model Lisa Ferguson-SellsNieves Velez de MendizabalDavid Small Original Research Article Open access 11 August 2021 Pages: 249 - 262
Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia Ming Liang ChanYulan QiJoshua Henshaw Original Research Article Open access 25 August 2021 Pages: 263 - 280
Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption Neil A. MillerRebecca H. GravesEdith M. Hessel Original Research Article Open access 30 August 2021 Pages: 281 - 293
Age-Related Change in Hepatic Clearance Inferred from Multiple Population Pharmacokinetic Studies: Comparison with Renal Clearance and Their Associations with Organ Weight and Blood Flow Kuretake SoejimaHiromi SatoAkihiro Hisaka Original Research Article 13 September 2021 Pages: 295 - 305
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling Jacqueline G. GerhartFernando O. Carreñothe Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee Original Research Article Open access 07 October 2021 Pages: 307 - 320
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates Wan-Yu ChuKim V. Anninkthe ALBINO Study Group Original Research Article Open access 07 October 2021 Pages: 321 - 333
Comment on: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update” Pieter-Jan De SutterJan De WaeleAn Vermeulen Letter to the Editor 07 January 2022 Pages: 335 - 336
Authors’ Reply to De Sutter, De Waele, and Vermeulen: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update” Emily N. DrwiegaKeith A. Rodvold Letter to the Editor 04 January 2022 Pages: 337 - 338